- Iowa dentist disciplined for unsanitary practice conditions
- ADA honors 10 new dentists for excellence in field
- Orthodontist pay vs. cost of living by state
- Oral surgeon pay vs. cost of living by state
- Wildfire smoke strafes Midwest, Northeast: 6 things healthcare leaders should know
- 9 pharmacy groups warn revised ACIP charter could delay vaccine access: 6 notes
- Private equity’s legal playbook for physician practices
- The outpatient orthopedic model built around doing less
- Where ASCs can find cost savings after the easy wins are gone
- NYU Langone grows South Florida presence with 2 practices
- The hidden cost of the GLP-1 boom: 5 notes
- ‘Hospitals without an outpatient footprint will struggle’: Health systems race to build ASC networks
- ‘Hospitals without an outpatient footprint will struggle’: Health systems race to build ASC networks
- Montefiore leader joins Northwell hospital as CNO, VP of patient care services
- Bad debt, charity care surge continues to squeeze hospitals
- 3 cardiology societies urge CMS to update TAVR coverage rules: 5 priorities
- UCSF nurses, physicians protest ED ‘boarding crisis’
- Inova’s next clinical chief keeps a fish pillow in her office
- Missouri outlaws insurance time limits on anesthesia: 5 things to know
- Texas hospital temporarily closes due to flooding
- Trump’s CDC Nominee Praises Vaccines, Without Vowing Independence From Kennedy
- Why ASCs should be watching the Medicare Advantage exodus
- LightForce Orthodontics appoints new CEO
- 39 behavioral health executive moves to know
- Good news for anesthesia
- MAX Surgical Specialty Management selects Sensei Cloud as enterprise practice management system
- Why some ASCs ‘are going to be left out’ of healthcare’s next era
- Median pay for anesthesiologists reaches $391K: Breakdown by state
- Is dental school becoming unattainable? 6 dentists weigh in
- Peak Dental Services becomes 1st DSO to deploy clinician well-being framework
- Aspen Dental continues expansion with South Carolina practice
- Texas safety net behavioral health provider projects $15M shortfall
- 4 dental deals totaling $308M
- Huahai poaches quality chief from Hengrui amid FDA manufacturing citations
- 24 new behavioral health study findings to know
- Maryhaven CEO steps down amid financial concerns
- GE HealthCare, Catholic Health strike 10-year, $500M technology partnership
- Thriveworks launches insight dashboard for referring providers
- What’s driving Arizona’s drug death surge? 6 things to know
- FDA Clears First Cholesterol Pill, Lipfendra, To Rival Costly Injections
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
- Statement on Proposed Regulation E-Delivery
- One Of The Largest Epidural Studies Ever Delivers Reassuring News For Parents
- Bipartisan Senate bill seeks to build vigilance around foreign companies making drugs in US
- Coalition for Health AI launches implementation initiative for public health agencies
- Vanda shifts Nereus marketing into high gear with Schumacher IndyCar sponsorship
- Could A Vaccine Prevent Pancreatic Cancer In Those At High Risk?
- Heatwaves During Pregnancy Could Affect Baby's Brain Development, Study Suggests
- Brain 'Microstimulation' Works Long-Term To Restore Sense Of Touch After Spinal Cord Injury
- Otters, bears and Pharma Lions: inside Gilead’s bronze-winning Cannes spot
- 'Night Owls' At Risk Of Wider Waistlines, Unhealthy Hearts
- Facing Funding Losses, States Call Out Big Businesses With Employees On Medicaid
- Listen to the Latest ‘KFF Health News Minute’
- Readers Share Personal Insights on Deadly Denials and Pregnancy Centers
- A Sales Tax on Doctor Visits and Medicine? In Missouri, Some Worry
- Merck scores at FDA as Lipfendra becomes world's first oral PCSK9 treatment
- UnitedHealth Group to maintain 'restless' even after topping investor's Q2 expectations, CEO says
- 6 weeks into California’s psychiatric staffing mandate: What hospital leaders should know
- The best opportunities to expand behavioral healthcare access
- PsychPlus acquires Koa Health to scale mental health platform
- Senate HELP committee grills CDC nominee Erica Schwartz on vaccine policy, resistance to political interference
- 2 states join in expanding psychologist prescribing authority
- Ohio behavioral health clinic owners indicted in $9.3M Medicaid fraud case
- Bipartisan House bill tying doc pay to inflation earns resounding applause from providers
- West Tennessee Healthcare expands critical care support through eICU Program in partnership with Philips and hellocare.ai
- Sanofi opens new chapters in Pfizer, Moderna mRNA patent litigation sagas
- Novo gains head start on Lilly with European Commission approval of Wegovy pill
- Merck touts Keytruda front-line win in endometrial cancer subtype, marking a PD-1 first
- Wildfire Smoke Puts Millions At Risk Across Midwest, Northeast
- Lark Health, Samsung team up on AI-powered health coach for U.S. seniors
- 340B drug purchases hit at least $100B in 2025, administrator reports
- Buzzy Veradermics shows its oral minoxidil can tackle female pattern hair loss, too
- No patent protection for Stelara? No problem for J&J as Tremfya fills the void
- Amazon Pharmacy partners with eNavvi to provide real-time medication pricing, delivery info to providers
- Are Microplastics Linked To Higher Heart Attack Risk?
- Impulsivity In Third Grade Could Point To Future Struggles
- AI Can Create 'Ghosts' Of Lost Loved Ones, But Would You Want To Meet Them?
- Blood Test May Predict Alzheimer's Risk Up To 10 Years Before Symptoms Begin
- Kelun scores sac-TMT win in first-line NSCLC population missing from Merck’s massive phase 3 program
- OpenAI’s health AI chief: ‘Bet on the models getting better’
- Knee Pain? Ragged Cartilage? Research Suggests Surgery's Not The Best Answer
- THC/CBD Combo Might Ease Agitation In Late-Stage Dementia
- Facing Funding Losses, States Call Out Big Businesses With Employees on Medicaid
- Full-body scan startup Neko Health scores $700M to break into the U.S. market
- Elevance Health leaves D.C. Medicaid market, mulls future exits
- Sanofi teams up with Special Olympics Unified Football World, raises respiratory health awareness
- Insilico signs on with CDMO Bora in $2.5B AI drug discovery deal
- CMS proposes major Medicare reforms to shift physician pay, phase out MIPS and expand ACO participation
- Judi Health rebrands PBM arm as Judi Rx, unveils Judi Care unit
- With FDA approval for its breast cancer blockbuster hopeful, Celcuity could ‘belong in the hands’ of a Big Pharma
- Anthropic bets bigger on healthcare with Optum tie-up, UST integration
- FTC, CVS unveil settlement in ongoing insulin pricing case
- HHS promises its final rule barring pediatric gender care providers from Medicare is still coming
- Director's Note on What to Expect at the 2026 Partnerships with Sites Summit
- AMA interoperability initiative brings structured clinical terminology to CPT codes
- Lettuce Suspected In Growing Multistate Cyclospora Outbreak
- Startup Sonata launches preventive healthcare membership, linking clinical decisions with AI
- Why Are Family Doctors Leaving The Workforce? Retirement, Burnout Creating A U.S. Primary Care 'Brain Drain'
- HCA Healthcare now expects ACA exchange impacts to exceed $1B in 2026
- Huyabio scores with Opdivo combo in 'milestone' skin cancer trial
- Unruly Patients Are Stressing ER Staff, Undermining Care
- Pain Patients Should Taper Opioids At Their Own Pace, Study Suggests
- Heatwaves Raise Hospital Admissions For Mental Health Woes
- U.S. Gun Suicides Hit Record High, Even As Firearm Deaths Decline Overall
- AstraZeneca pays up to $1.5B for EGFR lung cancer drug Zegfrovy from its spinoff Dizal
- Worried About Your Aging Parents? Welcome To The Caregiving Club
- Lawmakers Look To Make Abortion Shield Laws Less Dependent on Who’s Governor
- Knee Pain? Ragged Cartilage? Research Suggests Surgery’s Not the Best Answer
- Real Chemistry builds body of AI healthcare commercialization tools with Anatomi launch
- Inside agency view: Havas SO on authenticity, connection and pushing back against the ‘sea of sameness’
- Cellares' recent automated cell therapy wins have 'opened the biotech floodgates'
- Insulet, Calm join forces for diabetes care offerings with ‘Mind in Range’ wellness tools
- Remarks before the American-Hellenic Chamber of Commerce
- What Is An Aortic Dissection? The Condition That Killed Sen. Lindsey Graham
- Weight-Loss Drugs Help, But Exercise Is Still The Key To A Healthier Heart
- FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny
- GSK to seek FDA approval for Jemperli in small but high-profile cancer use after phase 2 win
- Smartphones Can Increase Seniors' Risk Of Depression
- Pro Soccer Players Show Signs Of Shrinking Brains
- Adderall Misuse Falls Sharply Among Young Adults, Study Finds
- New KFF Poll Reveals Who Is Most Likely To Endorse Vaccine Myths
- A New Option For Long-Term Care Costs
- As GOP Cries Fraud, Newsom Backs Medicaid Spending on Housing and Food
- Lupin recalls more than 2.5M prescription eye drop bottles, citing possible contamination
- Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending
- Katie Couric's Memory Loss Scare Puts Rare Brain Condition In Spotlight
- Mild COVID Can Lead To Long-Term Hidden Eye Problems
- LGBTQ+ People Less Likely To Be Screened For Some Common Cancers
- Smartphone App Uses Voice To Predict Asthma, COPD Flare-Ups
- Seniors Know How Sharp They Are At Any Given Time, Study Finds
- Patients Face A Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- AI Can Detect Previously Invisible MS Scars In The Brain
- A New Option for Long-Term Care Costs
- Remarks at the Society for Corporate Governance Conference
- GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Statement on the 2026 Regulatory Agenda
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- SCAN Health Plan, Alignment Healthcare sue to challenge CMS' MA star ratings recalculations
Michigan healthcare freedom community forum
Walgreens Boots Alliance Inc. has been supporting their stores with pharmacy profits as they lose a lot of money on their other retail lines. This bodes ill for controlling prescription drug costs in America, and will further challenge inner city residents seeking to fill their prescriptions:
Walgreens plans to close 1,200 stores as it looks for a turnaround
Walgreens’ stock has been hammered this year as consumer shopping patterns have changed, but the company’s latest earnings are getting better reception
By Emily Bary - October 15, 2024Walgreens Boots Alliance Inc. plans to shutter about 1,200 stores over the next three years in a bid to improve earnings.
The retail and pharmacy chain has struggled in recent years as shopping preferences have changed and consumers have moved to buy more products online. Walgreens previously embarked on a cost-cutting plan largely targeting the retail pharmacy business.
Walgreens announced the three-year plan for store closures alongside its earnings Tuesday morning, with the company noting that about 500 of the closures are expected in fiscal year 2025, which just began.
The company expects the move will prove immediately accretive to adjusted earnings per share and free cash flow.
After a deeply disappointing report three months back that brought a guidance cut and ushered in a 22% one-day stock decline, Walgreens’ latest results are getting a better reception on Wall Street. Shares are up 5% in premarket action Tuesday as Walgreens cleared the consensus view on both revenue and earnings.
The results “reflected our disciplined execution on cost management, working capital initiatives and capex reduction,” Chief Executive Tim Wentworth said in a release.
Walgreens’ revenue rose 6% to $37.5 billion, while analysts were looking for $35.8 billion.
The company’s U.S. retail pharmacy business saw a 6.5% sales gain in the quarter as well as an 8.3% rise in comparable sales. Pharmacy sales were up 9.6%, or 11.7% on a comparable-sales basis, reflecting “higher brand inflation and mix impact,” according to Walgreens’ earnings release.
Retail sales fell 3.5%, while comparable retail sales were down 1.7%, “reflecting a challenging retail environment and continued channel shift,” Walgreens said.
The company posted a fiscal fourth-quarter net loss of $3.0 billion, or $3.48 a share, compared with $180 million, or 21 cents a share, in the year-earlier period. The sizable loss included multiple non-cash charges.
On an adjusted basis, Walgreens earned 39 cents a share, while analysts tracked by FactSet were modeling 36 cents a share.
For fiscal 2025, Walgreens models $1.40 to $1.80 in adjusted earnings per share, while the FactSet consensus was for $1.72. The company expects its U.S. healthcare business and international business to grow, while the U.S. retail pharmacy business is anticipated to decline. The company is also looking for $147 billion to $151 billion in fiscal 2025, sales, while analysts were modeling $147.6 billion.
“Fiscal 2025 will be an important rebasing year as we advance our strategy to drive value creation,” Wentworth said. “This turnaround will take time, but we are confident it will yield significant financial and consumer benefits over the long term.”
Walgreens shares are down 66% so far this year.
NPR reporter Alina Selyukh has posted a backgrounder on the troubles at CVS and Walgreen's:
https://www.npr.org/2024/10/16/nx-s1-5154129/cvs-and-walgreens-closing-stores-why
CVS and Walgreens are ailing. Here’s why
By Alina Selyukh - October 16, 2024Not too long after Tim Wentworth became CEO of Walgreens, he revealed a stunning figure: Roughly a quarter of the pharmacy chain’s stores do not make money.
On Tuesday, he said 1,200 of those stores will close over three years. That’s two weeks after rival CVS announced layoffs of 2,900 corporate staff. Both chains are on a multibillion-dollar cost-saving spree — closing hundreds of locations, cutting thousands of jobs and, really, reconsidering their role in Americans’ lives.
The slow simmer of mistakes and misfortunes has come to a boil for the biggest U.S. drugstore chains. They’ve accumulated too many stores at a time of changing shopper habits. They’re saddled with numerous government fines and a particularly ailing relationship with health insurers.
The problem of stores
CVS and Walgreens have some notable differences. Walgreens, which also owns the British drugstore Boots, is more singularly focused on its pharmacy business. CVS has expanded further into health care through mergers with insurer Aetna and Caremark, a pharmacy benefit manager that helps insurers negotiate prescription drug coverage and costs. Yet the two companies have made similar missteps.
The simplest part of the problem is scale. CVS and Walgreens grew massive nationwide footprints of more than 9,000 and 8,000 stores, respectively. They gobbled up mom-and-pop shops and signed long-term leases for prime locations on street corners.
Now, shoppers regularly complain about chronically understaffed stores, with products locked up to prevent theft. The shelves of snacks, makeup, greeting cards and cleaning products were meant to boost profits. But sales have sagged for years — a result of a losing battle with Amazon, Walmart, Costco, grocery and dollar stores.
CVS and Walgreens “probably do have too many stores because they overexpanded, but the bigger problem is that the stores that they have are not very good,” said Neil Saunders, retail analyst at the firm GlobalData.
The chains have failed to add new incentives for shoppers, beyond photo booths and returns drop-off centers, says Anshuman Jaiswal, a longtime consultant to retailers and pharmacies. And neither chain has built a meaningful online presence designed to give customers what they need.
“If you go to CVS.com or Walgreens.com, if you are placing an order for cough syrup, why don't I sell chicken broth as a product recommendation immediately?” Jaiswal says. “It's about reimagining the business model.”
The problem of prescriptions
Given the retail struggles, pharmacies could perhaps simply ditch the convenience store and focus on selling medicine — except CVS and Walgreens say it’s harder and harder to make a profit from this part of their business.
Years ago, a big shift in the power balance between pharmacies and health insurers revealed the limits of drugstores’ leverage.
“Historically, there was a view that there was a lot of customer loyalty to their specific retail pharmacy … and that patients, or consumers, would be all up in arms if they were forced to move their prescriptions,” says Brian Tanquilut, health care services analyst at the investment bank Jefferies.
Walgreens tested this theory about a decade ago when it got into a public fight with Express Scripts, a pharmacy benefit manager that worked with major health insurers.
Walgreens and Express Scripts played a game of chicken over how much Walgreens should earn from prescriptions — and Walgreens lost. For a time, it got kicked out of insurance networks used by millions of people, who simply went elsewhere to get their medicine at the lower in-network prices.
“What that did was to prove that patient loyalty is not to the retail pharmacy, but it actually is whatever my insurance is willing to pay,” Tanquilut says. “And that opened the door for the payers to keep pushing pricing down on retail pharmacy chains.”
Hoping reinvention is the cure
These days, CVS and Walgreens are facing tough competition from pharmacies that don’t depend as much on profits from prescriptions because they’re part of retail giants, including Walmart and Costco. The drugstore chains also have spent millions of dollars on government fines over allegations of unsafe staffing levels, overbilling government insurance programs and contributing to the opioid epidemic.
Over the years, CVS and Walgreens attempted to reframe themselves as health care hubs, expanding primary-care clinics. But these operations cost time and money.
On Tuesday, Walgreens CEO Wentworth said his chain is “reorienting to its legacy strength as a retail pharmacy-led company.” CVS is reportedly weighing a breakup to undo its mergers with Aetna and Caremark.
Both companies are also proposing new structures for how they want to be paid for filling prescriptions, hoping this is the big shot in the arm they need.
"I'm very confident that over a two- to three-year period we will have reset the framework for reimbursement discussions," Wentworth told investors on Tuesday. “We are in the early stages of a turnaround that will take time.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























